National Guideline Clearinghouse | Guidelines by Topic: Myasthenia Gravis

National Guideline Clearinghouse | Guidelines by Topic: Myasthenia Gravis

Guidelines by Topic

Disease/Condition > Diseases (2243) > Nervous System Diseases (596) > Autoimmune Diseases of the Nervous System (25) >

Myasthenia Gravis (5)

1-5 of 5
1. Care of the patient with myasthenia gravis. 2013. NGC:009935 American Association of Neuroscience Nurses - Professional Association. View all guidelines by the developer(s) Compare Selected
2. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. 2012 Mar 27. NGC:009085 American Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
3. Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. 1996 (revised 2011 Jan 18). NGC:008274 American Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
4. Guidelines for treatment of autoimmune neuromuscular transmission disorders. 2006 Jul (revised 2010 Jul). NGC:007905 European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
5. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. 2000 Jul (reaffirmed 2010 Jul 10). NGC:002052 American Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
1-5 of 5